Oxford Global Conferences are proud to present the 4th Annual Pharma R&D Asia Congress to be held on the 27th & 28th February 2014 in Shanghai, China.
The booming growth of research and development activities in Asia and Asia Pacific regions has advanced the opportunity for business success. Industry leaders believe that the Asian market will overtake the US by 2020. Our conference will bring together industry leaders to discuss the potential and future of the R&D industry. Our exclusive networking sessions will offer opportunities to meet with potential partners and form unique business relationships.
Expert speakers will discuss strategies to advance research and development activities in Asia. They will offer insights into the importance of collaborations between eastern and western countries for advancing global drug development. Topics will also cover methods to choose correct outsourcing partners for business needs, attaining successful mergers and acquisitions and opportunities for multi-national companies in emerging markets.
Confirmed Speakers Include:
• Yariv Hefez, VP, Merck, Switzerland
• Beverly Lui, Director, Amgen, China
• Jian Li, Director, Global R&D Sanofi, China
• Yuan-Hua Ding, Senior Director, Pfizer Worldwide R&D, USA
• Simon McErlane, Senior Medical, Takeda Development Center Asia, Singapore
The event will provide the opportunity for networking and knowledge sharing in the expanding clinical market in Asia and Asia Pacific regions. Over the two days the event will attract over 150 senior-level international decision makers working in discovery, R&D, translational sciences, medical affairs and outsourcing & partnerships from pharma and biotech companies in Asia, Australia, the USA and Europe.
Please contact Freda Shi at +65 6570 2208 or email [email protected]
to express your interest today!